Objective Epilepsy treatment during pregnancy is still challenging. The study is aimed at
comparing the efficacy and safety of carbamazepine (CBZ), lamotrigine (LTG) and …

Background and Purpose: Epilepsy during pregnancy is a therapeutic challenge. Since the
1990s, the number of licensed antiepileptic drugs has substantially increased, but safety …

Objective Levetiracetam is increasingly used in pregnant women with epilepsy. Although
teratogenic effects have not been observed so far, data on the risks of spontaneous abortion …

Background and Objectives Pharmacologic treatment of epilepsy in pregnant women is
balancing between risks for the mother and fetus. Levetiracetam (LEV) is considered to be …

Over a million women with epilepsy are of childbearing age in the USA and require careful
consideration of not only type of antiepileptic drug (AED) but also dosage, in the event of a …

The safety and efficacy of novel anticonvulsants during pregnancy in women with epilepsy
are not well established. Although there are a variety of pregnancy registries accruing data …

Objectives To assess the effectiveness of the newer antiepileptic drugs (AED s)—in
particular lamotrigine, topiramate, and levetiracetam—in controlling epileptic seizures in …

RESULTS: In this study (n= 99), 35 women received carbamazepine, 28 received LEV, 15
received valproate (VPA), 13 received phenytoin (PHT), three each received oxcarbazepine …

Introduction People with epilepsy have to face many challenges, including regular follow-
ups, the need to take antiseizure medications (ASMs), and the fear of seizures. Pregnant …

Women with epilepsy (WWE) wishing for a child represent a highly relevant subgroup of
epilepsy patients. The treating epileptologist needs to delineate the epilepsy syndrome and …